Home › NDC Lookup › Ingredients › Lidocaine Hcl And Menthol › 84126-0318-03
Nervive Pain Relieving Cream Lidocaine HCl and Menthol 4 g/100g; 1 g/100g Cream, 1 tube — NDC 84126-0318-03 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Nervive Pain Relieving Cream Lidocaine HCl and Menthol 4 g/100g; 1 g/100g Cream, 1 tube — NDC 84126-318-03 (Billing 84126-0318-03)

by The Procter & Gamble Manufacturing Company · 1 TUBE in 1 CARTON / 85.1 g in 1 TUBE

This is a package of 1 tube of Nervive Pain Relieving Cream Lidocaine HCl and Menthol 4 g/100g; 1 g/100g Cream from The Procter & Gamble Manufacturing Company, marketed since Aug 2024 and currently FDA-listed. It is this product's only package size.

NDC 84126-0318-03
🏷️ FDA NDC (as labeled) 84126-318-03 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Oct 8, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 84126-318-03 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
84126 labeler · 318 product · 03 package
Package marketed since
Aug 12, 2024
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Barcode (UPC-A, from the NDC)
3 8412631803 5
FDA record last changed
Oct 8, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 84126-318-03
Product NDC 84126-318
11-digit billing NDC 84126031803
Application # M017
SPL Set ID 1e8bfb1e-8f5a-d0f3-e063-6294a90a752a
Established class (EPC) Amide Local Anesthetic; Antiarrhythmic
Physiologic effect Local Anesthesia
Chemical class Amides
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2024-08-12
Route TOPICAL
Dosage form CREAM
Substance LIDOCAINE HYDROCHLORIDE ANHYDROUS; MENTHOL
Why two NDCs? The FDA registers this code as 84126-318-03 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 84126-0318-03. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

🧪 What is this product?

Nervive Pain Relieving Cream is a topical cream containing lidocaine hydrochloride and menthol. Lidocaine is a local anesthetic typically used to numb pain in the area where it is applied, while menthol creates a cooling sensation that is commonly included in pain-relief products for topical use. This is an over-the-counter monograph product, meaning it is marketed under FDA's established rules for this category of topical pain-relief creams.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
84126-0318-03 You're viewing this Main listing 1 TUBE in 1 CARTON / 85.1 g in 1 TUBE 2024-08-12 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Walgreens Cool n Heat 1 g/100g; 4 g/100g 00363-3036-02 Walgreens 1 bottle — — FDA listed —
Triderma Pain Relief 4 g/100g; 1 g/100g 10738-0073-20 Genuine 1 jar — — FDA listed —
Icy Hot with Lidocaine Pain Relieving .4 g/g; .1 g/g 41167-1710-00 Chattem, 1 tube — — FDA listed —
Meijer Cold and Hot Pain Relieving Analgesic 40 mg/g; 10 mg/g 41250-0355-01 Meijer 1 bottle — — FDA listed —
CVS Health Maximum Strength Lidocaine Pain Relief Cream Plus Menthol 40 mg/g; 10 mg/g 59779-0910-01 CVS 1 bottle — — FDA listed —
Pain Relief 1 mg/100mg; 4 mg/100mg 72042-0001-01 HUMN 1 tube — — FDA listed —
Workvie 1 g/100g; 4 g/100g 72393-0203-25 Marketites 71 g — — FDA listed —
Insta Relief Dm 40 mg/mL; 10 mg/mL 72465-0600-00 DM 118 ml — — FDA listed —
Bakers Best Maximum Strength Pain Relief 40 mg/g; 10 mg/g 76102-0031-02 Baker's 56.7 g — — FDA listed —
Zylotrol Pain Relieving 4 g/100g; 1 g/100g 76420-0560-04 Asclemed 102 g — — FDA listed —
SANTO REMEDIO Alivio Pain Relieving Lavender Scent 40 mg/mL; 10 mg/mL 81352-0519-00 SANTO 1 tube — — FDA listed —
Zylotrol Pain Relieving 4 g/100g; 1 g/100g 81902-0230-01 Whitestone 102 g — — FDA listed —
BlueStop Max 40 mg/g; 10 mg/g 82714-0002-01 Clavel 1 tube — — FDA listed —
Rapid Pain-Relief Topical 40 mg/mL; 10 mg/mL 82798-0295-02 NORDIC 60 ml — — FDA listed —
LidoSync 3.1 g/76.5g; .8 g/76.5g 82944-0200-01 iON 1 bottle — — FDA listed —
Nervive Pain Relieving Cream 4 g/100g; 1 g/100gthis 84126-0318-03 The 1 tube — — FDA listed —
Dermatool Nerve Care 1 g/100g; 4 g/100g 84728-0359-05 Papalo 1 bottle — — FDA listed —
5Kind DMSO 4 Lidocaine HCl Pain Relieving 40 mg/mL; 10 mg/mL 85978-0929-00 5KIND 118 ml — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2024
On the market since
Aug 2024
📍
2026
Currently FDA-listed
2 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color white
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 3K9958V90M
    A liquid solvent derived from fermentation or chemical synthesis. In medicines, alcohol dissolves active ingredients, helps preserve the product, and improves how the body absorbs certain drugs.
  • UNII LU49E6626Q
    A synthetic organic compound used as a pH buffer and neutralizing agent in medicines. It helps maintain the proper acidity level in liquid formulations to improve stability and comfort.
  • UNII 4ZK9VP326R
    A silicone-based polymer made from long-chain oils and dimethicone. Used as a thickener, emulsifier, and texture agent to create a smooth, uniform consistency in creams and lotions.
  • UNII Q95M2P1KJL
    A silicone-based ingredient that acts as a lubricant and glidant. It helps the tablet or capsule move smoothly through manufacturing equipment and improves powder flow during production.
  • UNII 132584PQMO
    A synthetic polymer used as a thickening agent and stabilizer in gels and creams. It helps create the product's texture, keeps ingredients evenly mixed, and improves how the medicine spreads on skin.
  • UNII 921FTA1500
    A synthetic compound derived from cetyl alcohol and ethylene oxide. It acts as an emulsifier and solubilizer to help blend oil and water components together in liquid formulations.
  • UNII 2DMT128M1S
    A waxy solid derived from plant or animal sources. It acts as an emulsifier to blend oil and water components, and also thickens the medicine to give it the right texture and consistency.
  • UNII 2V6E5WN99N
    A lipid compound made from fatty acids, used as an emulsifier and stabilizer in medicines to help mix oil and water-based ingredients and keep them from separating.
  • UNII 92RU3N3Y1O
    Dimethicone is a silicone-based oil that acts as an anti-foaming agent and lubricant in medicines. It reduces gas bubbles in liquid formulations and helps coat and protect the stomach lining when ingested.
  • UNII 7FLD91C86K
    Edetate disodium is a chemical compound that binds and removes certain metal ions. In medicines, it acts as a preservative and stabilizer by preventing metals like calcium from interfering with the product's shelf life and consistency.
  • UNII 147D247K3P
    Ethylhexylglycerin is a synthetic preservative used to prevent bacteria and mold from growing in medicines and personal care products. It helps keep the product safe and stable throughout its shelf life.
  • UNII 230OU9XXE4
    A waxy substance made from glycerin and stearic acid that acts as an emulsifier to blend oily and watery ingredients together. It also helps thicken and stabilize the medicine's texture.
  • UNII 86FQE96TZ4
    A synthetic polymer, this ingredient acts as a thickener and suspending agent in liquid formulations. It helps maintain uniform consistency and keeps particles evenly distributed throughout the medicine.
  • UNII 918X1OUF1E
    Isohexadecane is a synthetic hydrocarbon oil used as an emollient and solvent in topical medicines. It helps dissolve active ingredients and improves spreadability and absorption through the skin.
  • UNII HIE492ZZ3T
    Phenoxyethanol is a synthetic preservative and antimicrobial agent used to prevent bacterial and fungal growth in medicines and cosmetic products, extending shelf life and maintaining product safety.
  • UNII 71YMM1X75O
    A synthetic oily substance made from plant-based fatty acids. It acts as an emulsifier and solubilizer to help mix oil and water-based ingredients, ensuring the medicine stays uniform and dissolves properly.
  • UNII CAL22UVI4M
    A synthetic emulsifier derived from sorbitol and fatty acids. It helps mix oil and water-based ingredients together and improves the texture and stability of the medicine.
  • UNII 01S2G2C1E4
    Sorbitan isostearate is an emulsifier derived from sorbitol and isostearic acid. It helps mix oil and water-based ingredients together and keeps them blended throughout the medicine's shelf life.
  • UNII 53J3F32P58
    A synthetic detergent derived from stearic acid, a fatty substance. It helps dissolve or distribute oil-based ingredients evenly throughout the medicine, acting as an emulsifier and solubilizer in tablets and capsules.
  • UNII R0ZB2556P8
    Tocopherol is a form of vitamin E derived from plant oils. It acts as an antioxidant in medicines to prevent oils and fats from breaking down and spoiling during storage.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

21 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesacrylates/C10-30 alkyl acrylate crosspolymer, alcohol denat., aminomethylpropanol, C30-45 alkyl cetearyl dimethicone crosspolymer, caprylyl methicone, ceteth-20 phosphate, cetostearyl alcohol, dicetyl phosphate, dimethicone, edetate disodium, ethylhexylglycerin, glyceryl stearate, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, isohexadecane, phenoxyethanol, polyoxyl 15 hydroxystearate, polysorbate 60, sorbitan isostearate, steareth-21, tocopherol, water

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerThe Procter & Gamble Manufacturing Company
FDA applicationM017 (OTC MONOGRAPH DRUG)
Labeler code84126
First marketedAug 2024
Product typeHuman Otc Drug
Portfolio851 products on file

More NDCs from The Procter & Gamble Manufacturing Company labeler code 84126

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🆘 Overdosage 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 5 words ▾

Use temporarily relieves minor pain

⏱️ Dosage and Administration 55 words ▾

Directions adults and children over 12 years: apply a thin layer to affected area every 6 to 8 hours do not exceed 3 applications in a 24 hour period massage into painful area until thoroughly absorbed into skin AFTER APPLYING, WASH HANDS WITH SOAP AND WATE R children 12 years or younger: ask a doctor

⚠️ Warnings ~1 min read ▾

Warnings For external use only Flammable keep away from heat and open flame Do not use If you have had an allergic reaction to lidocaine or other local anesthetics on large areas of the body or on cut, irritated, blistered, or swollen skin on puncture wounds for more than one week without consulting a doctor When using this product use only as directed. Read and follow all directions and warnings on this carton. avoid contact with eyes and mucous membranes rare cases of serious burns have been reported with products of this type do not apply to wounds or damaged, broken or irritated skin do not bandage tightly or apply local heat (such as heating pads) or a medicated patch to the area of use a transient burning sensation may occur upon application but generally disappears in several days avoid applying into skin folds Stop use and ask a doctor if condition worsens severe burning sensation, redness, rash or irritation develops symptoms persist for more than 7 days or clear up and occur again within a few days you experience signs of skin injury, such as pain, swelling, or blistering where the product was applied If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children and pets. If swallowed, get medical help or contact a Poison Control Center right away.

🆘 Overdosage 13 words ▾

If swallowed, get medical help or contact a Poison Control Center right away.

📦 Storage and Handling 7 words ▾

Store at no greater than 25°C (77°F).

🧪 Active Ingredient 12 words ▾

Active ingredients Lidocaine HCl 4% Menthol 1% Purpose Topical anesthetic Topical analgesic

🧪 Inactive Ingredients 45 words ▾

Inactive ingredients acrylates/C10-30 alkyl acrylate crosspolymer, alcohol denat., aminomethylpropanol, C30-45 alkyl cetearyl dimethicone crosspolymer, caprylyl methicone, ceteth-20 phosphate, cetostearyl alcohol, dicetyl phosphate, dimethicone, edetate disodium, ethylhexylglycerin, glyceryl stearate, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, isohexadecane, phenoxyethanol, polyoxyl 15 hydroxystearate, polysorbate 60, sorbitan isostearate, steareth-21, tocopherol, water

🎯 Purpose 5 words ▾

Purpose Topical anesthetic Topical analgesic

📄 Do Not Use 42 words ▾

Do not use If you have had an allergic reaction to lidocaine or other local anesthetics on large areas of the body or on cut, irritated, blistered, or swollen skin on puncture wounds for more than one week without consulting a doctor

📄 When Using This Product 89 words ▾

When using this product use only as directed. Read and follow all directions and warnings on this carton. avoid contact with eyes and mucous membranes rare cases of serious burns have been reported with products of this type do not apply to wounds or damaged, broken or irritated skin do not bandage tightly or apply local heat (such as heating pads) or a medicated patch to the area of use a transient burning sensation may occur upon application but generally disappears in several days avoid applying into skin folds

📄 Stop Use and Ask a Doctor If 51 words ▾

Stop use and ask a doctor if condition worsens severe burning sensation, redness, rash or irritation develops symptoms persist for more than 7 days or clear up and occur again within a few days you experience signs of skin injury, such as pain, swelling, or blistering where the product was applied

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 8 words ▾

Keep out of reach of children and pets.

📄 Questions or Comments 2 words ▾

Questions? 1-855-446-4345

📄 Package Label / Principal Display Panel 33 words ▾

PRINCIPAL DISPLAY PANEL -

3.0OZ NERVIVE™ PAIN RELIEVING CREAM LIDOCAINE HCl & MENTHOL PAIN RELIEF CREAM Blocks NERVE PAIN SIGNALS Max Strength Formula^ MEDICATED CREAM NET WT

3.0OZ (85.1 g) 318

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Nervive Pain Relieving Cream (this brand).

Top reported reactions

Fall3
Fatigue3
Pain In Extremity3
Neuralgia2
Tachycardia2
Abdominal Discomfort1
Activated Partial Thromboplastin Time Prolonged1

Age at onset

Adolescent1
Adult1
Elderly3

Reporter sex

15 reports
Male · 23%
Female · 77%

Serious outcomes

Hospitalization4
Reports over time (by year) — tap or hover for the count & year
2022 2023 2024 2026 7 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by The Procter & Gamble Manufacturing Company. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
The Procter & Gamble Manufacturing Company is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 84126-0317-03 · The 84126-0319-05 · The →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.